Intravenous infusions in chronic pain management

Pain Physician

Volumn 16, Issue 3, 2013, Pages 231-249

  Kosharskyy, Boleslav ^a   Almonte, Wilson ^a   Shaparin, Naum ^a   Pappagallo, Marco ^b   Smith, Howard ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b New Medical Home for Chronic Pain   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Bisphosphonates; Chronic pain; Dexmedetomidine; Intravenous infusions in chronic pain management; Ketamine; Lidocaine; Phentolamine

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; DEXMEDETOMIDINE; GABAPENTIN; KETAMINE; LIDOCAINE; MORPHINE; NERIDRONIC ACID; PAMIDRONIC ACID; PHENTOLAMINE; PLACEBO;

ACUTE PHASE REACTION; ANALGESIA; BEHAVIOR DISORDER; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME; CONFUSION; DIABETIC NEUROPATHY; DISABILITY; DIZZINESS; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG USE; FIBROMYALGIA; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEALTH CARE COST; HEART ARRHYTHMIA; HEMODYNAMIC INSTABILITY; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; JAW OSTEONECROSIS; METALLIC TASTE; MORBIDITY; MORTALITY; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; PARESTHESIA; PATHOPHYSIOLOGY; PHANTOM PAIN; POSTHERPETIC NEURALGIA; PREVALENCE; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; SEIZURE; SINUS ARREST; SOMNOLENCE; SPINAL CORD INJURY; TACHYCARDIA; TREMOR; UNITED STATES; VOMITING; XEROSTOMIA;

ANALGESICS, NON-NARCOTIC; CHRONIC PAIN; HUMANS; INFUSIONS, INTRAVENOUS; PAIN MANAGEMENT;

EID: 84878258039     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Calatayud J, Gonzalez A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology 2003; 98:1503-1508.
2. Bartlett EE, Hutaserani Q. Lidocaine (xylocaine) for the relief of postoperative pain. J Am Med Womens Assoc 1962; 17:809-815.
3. Groudine SB, Fisher HA, Kaufman RP Jr, Patel MK, Wilkins LJ, Mehta SA, Lumb PD. Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 1998; 86:235-239.
4. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982; 54:501-505.
5. Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 2004; 108:237-247.
6. Matzner O, Devor M. Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na channels. J Neurophysiol 1994; 72:349-359.
7. Wall PD, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983; 17:321-339.
8. Devor M, Seltzer Z. Pathophysiology of damaged nerves in relation to chronic pain. In: Wall PD, Melzack R (eds). Textbook of Pain. 4th Edition. Churchill Livingstone, London, UK, 1999, pp 129-164.
9. Dong XW, Goregoaker S, Engler H, Zhou X, Mark L, Crona J, Terry R, Hunter J, Priestley T. Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience 2007; 146:812-821.
10. Nieto FR, Entrena JM, Cendan CM, Pozo ED, Vela JM, Baeyens JM. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 2008; 137:520-531.
11. Challapalli V, Tremont-Lukats IW, Mc-Nicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 2005; CD003345.
12. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002; 95:985-991.
13. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. Regional block and mexiletine: The effect on pain after cancer breast surgery. Reg Anesth Pain Med 2001; 26:223-228.
14. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87:7-17.
15. Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, Gold MS, Porreca F, Strichartz GR. The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain 2006; 7:S1-29.
16. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review and meta-analysis. Anesth Analg 2005; 101:1738-1749.
17. Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, et al. Intravenous lidocaine in central pain: A doubleblind, placebo-controlled, psychophysical study. Neurology 2000; 54:564-574.
18. Finnerup NB, Biering-Sørensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH, Bach FW, Jensen TS. Intravenous lidocaine relieves spinal cord injury pain: A randomized controlled trial. Anesthesiology 2005; 102:1023-1030.
19. Kvarnstrom A, Karlsten R, Quiding H, Gordh T. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol Scand 2004; 48:498-506.
20. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003; 23:963-971.
21. Rosen N, Marmura M, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: A retrospective case series. Headache 2009; 49:286-291.
22. Viola V, Newnham HH, Simpson RW. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. J Diabetes Complications 2006; 20:34-39.
23. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J. Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy? Pain 1987; 28:69-75.
24. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexilitine: A prospective study. Journal of Pain Symptom Management 1996; 12:161-167.
25. Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, doublemasked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006; 22:266-271.
26. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 2004; 62:218-225.
27. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41:1024-1028.
28. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996; 66:69-77.
29. Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. Journal of Pain and Symptom Management 1999; 17:429-433.
30. Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL. Concentrationeffect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology 2000; 92:75-83.
31. Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, doublemasked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006; 22:266-271.
32. Schwartzman RJ, Patel M, Grothusen JR, Alexacner GM. EFficace of 5-day continuous lidocaine infusion for the treatment of refractory complex regional pain syndrome. Pain Medicine 2009; 10:401-412.
33. Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain 2012; 28:567-572.
34. Wu CL, Tella P, Staats PS, Vaslav R, Kazim DA, Wesselmann U, Raja SN. Analgesic effects of intravenous lidocaine and morphine on postamputation pain: A randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology 2002; 96:841-848.
35. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia, effects of intravenous morphine, lidocaine and ketamine. Scan J Rheumatol 1995; 24:360-365.
36. Raphael JH, Southall JL, Treharne GJ, Kitas GD. Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 2002; 3:21.
37. Schafranski MD, Malucelli T, Machado F, Takeshi H, Kaiber F, Schmidt C, Harth F. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clinical Rheumatology 2009; 28:853-855.
38. Ichimata M, Ikebe H, Yoshitake S, Hattori S, Iwasaka H, Noguchi T. Analgesic effects of flecainide on postherpetic neuralgia. Int J Clin Pharmacol Res 2001; 21:15-19.
39. Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987; 28:45-50.
40. Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol 2006; 17:592-604.
41. Childers WE Jr, Baudy RB. N-methyl-Daspartate antagonists and neuropathic pain: The search for relief. J Med Chem 2007; 50:2557-2562.
42. Raith K, Hochhaus G. Drugs used in the treatment of opioid tolerance and physical dependence: A review. Int J Clin Pharmacol Ther 2004; 42:191-203.
43. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain-multiple drug targets and multiple uses. Curr Pharm Des 2005; 11:2977-2994.
44. Laube B, Kuhse J, Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 1998; 18:2954-2961.
45. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on Nmethyl-D-aspartate receptor activation. Neurosurgery 1995; 37:1080-1087.
46. Kvarnstrom A, Karlsten R, Quiding H, Gordh T. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol Scand 2004; 48:498-506.
47. Eichenberger U, Neff F, Sveticic G, Björgo S, Petersen-Felix S, Arendt-Nielsen L, Curatolo M. Chronic phantom limb pain: The effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 2008; 106:1265-1273.
48. Jørum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-Daspartate (NMDA) receptor antagonist ketamine-a double blind, cross-over comparison with alfentanil and placebo. Pain 2003; 101:229-235.
49. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain 1996; 64:283-291.
50. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 2001; 91:177-187.
51. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58:347-354.
52. Gottrup H, Bach FW, Juhl G, Jensen TS. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology 2006; 104:527-536.
53. Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: An open-label phase II study. Pain Med 2008; 9:1173-1201.
54. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY, Dahan A. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 2009; 145:304-311.
55. Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study. Pain 2009; 147:107-115.
56. Goldberg ME, Domsky R, Scaringe D, Hirsh R, Dotson J, Sharaf I, Torjman MC, Schwartzman RJ. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005; 8:175-179.
57. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004; 5:263-275.
58. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sörensen J, Johnson A, Gerdle B, Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000; 85:483-491.
59. Noppers I, Niesters M, Swartjes M, Bauer M, Aarts L, Geleijnse N, Mooren R, Dahan A, Sarton E. Absence of longterm analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo-controlled trial. Eur J Pain 2011; 15:942-949.
60. Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 2000; 20:246-252.
61. Haines DR, Gaines SP. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. Pain 1999; 83:283-287.
62. Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999; 90:1528-1533.
63. Vickers ER, Cousins MJ. Neuropathic orofacial pain. Part 2--Diagnostic procedures, treatment guidelines and case reports. Aust Endod J 2000; 26:53-63.
64. Chaturvedi A, Dash HH. Sympathetic blockade for the relief of chronic pain. J Indian Med Assoc 2001; 99:698-703.
65. Gamal G, Helaly M, Labib YM. Superior hypogastric block: Transdiscal versus classic posterior approach in pelvic cancer pain. Clin J Pain 2006; 22:544-547.
66. Longmire DR. An electrophysiological approach to the evaluation of regional sympathetic dysfunction: A proposed classification. Pain Physician 2006; 9:69-82.
67. Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev 2003; CD002918.
68. Martinez-Lavin M. Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol 2001; 19:1-3.
69. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 2007; 102:430-438.
70. Liu X, Chung K, Chung JM. Ectopic discharges and adrenergic sensitivity of sensory neurons after spinal nerve injury. Brain Res 1999; 849:244-247.
71. Shyu BC, Danielsen N, Andersson SA, Dahlin LB. Effects of sympathetic stimulation on C-fibre response after peripheral nerve compression: An experimental study in the rabbit common peroneal nerve. Acta Physiol Scand 1990; 140:237-243.
72. Lavand'homme PM, Ma W, De Kock M, Eisenach JC. Perineural alpha (2A)-adrenoceptor activation inhibits spinal cord neuroplasticity and tactile allodynia after nerve injury. Anesthesiology 2002; 97:972-980.
73. Bossut DF, Shea VK, Perl ER. Sympathectomy induces adrenergic excitability of cutaneous C-fiber nociceptors. J Neurophysiol 1996; 75:514-517.
74. Drummond PD, Skipworth S, Finch PM. Alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Lond) 1996; 91:73-77.
75. Raja SN, Davis KD, Campbell JN. The adrenergic pharmacology of sympathetically-maintained pain. J Reconstr Microsurg 1992; 8:63-69.
76. Devor M, Janig W, Michaelis M. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol 1994; 71:38-47.
77. McLachlan EM, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993; 363:543-546.
78. Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): Complete inhibition of sympathetic nerve activity with recovery. Arch Neurol 1999; 56:613-620.
79. Galer BS. Peak pain relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Preliminary report. Reg Anesth 1995; 20:444-447.
80. Raja SN, Treede RD, Davis KD, Campbell JN. Systemic alpha-adrenergic blockade with phentolamine: A diagnostic test for sympathetically maintained pain. Anesthesiology 1991; 74:691-698.
81. Yasukawa M, Yasukawa K, Kamiizumi Y, Yokoyama R. Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma. J Anesth 2007; 21:420-423.
82. Shir Y, Cameron LB, Raja SN, Bourke DL. The safety on intravenous phentolamine administration in patients with neuropathic pain. Anesth Analg 1993; 76:1008-1011.
83. Chrysostomou C, Schmitt CG. Dexmedetomidine: Sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol 2008; 4:619-627.
84. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: Dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009; 25:451-469.
85. Hospira Inc. Precedex (dexmedetomidine hydrochloride) injection: Prescribing information [online]. Available from URL: www.accessdata.fda.gov/drugsatfda_ docs/label/2010/021038s017lbl.pdf [Accessed 2011 Jul 14].
86. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: A meta-analysis. Intensive Care Med 2010; 36:926-939.
87. Murthy TVSP, Singh R. Alpha 2 adrenoceptor agonist-dexmedetomidine role in anaesthesia and intensive care: A clinical review. J Anaesthesiol Clin Pharmacol2009; 25:267-272.
88. Haselman MA. Dexmedetomidine: A useful adjunct to consider in some highrisk situations. AANA J 2008; 76:335-339.
89. Dyck JB, Shafer SL. Dexmedetomidine: Pharmacokinetics and pharmacodynamics. Anaesth Pharm Rev 1993; 1:238-245.
90. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002; 88:669-675.
91. Al-Metwalli RR, Mowafi HA, Ismail SA, Siddiqui AK, Al-Ghamdi AM, Shafi MA, El-Saleh AR. Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery. Br J Anaesth 2008; 101:395-399.
92. Chan AK, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother 2010; 11:2849-2868.
93. Jung HS, Joo JD, Jeon YS, Lee JA, Kim DW, In JH, Rhee HY, Choi JW. Comparison of an intraoperative infusion of desmedetomidine or remifentanil on perioperative haemodynamics, hypnosis and sedation, and postoperative pain control. J Int Med Res 2011; 39:1890-1899.
94. Techanivate A, Dusitkasem S, Anuwattanavit C. Dexmedetomidine compare with fentanyl for postoperative analgesia in outpatient gynecologic laparoscopy: A randomized controlled trial. J Med Assoc Thai 2012; 95:383-390.
95. Blaudszun G, Lysakowski C, Elia N, Tramér MR. Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: Systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116:1312-1322.
96. Zheng Y, Chi S, Liu Y, Zhang J, Zhang W, Zhang J, Gu X, Ma Z. Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of Nmethyl-d-aspartate receptor 2B subunit. Brain Res Bull 2012; 87:427-431.
97. Nama S, Meenan DR, Fritz WT. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS. Pain Physician 2010; 13:365-368.
98. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699-705.
99. Yanow J, Pappagallo M, Pillai L. Complex Regional Pain Syndrome (CRPS/RSD) and neuropathic pain: Role of intravenous bisphosphonates as analgesics. Scientific World Journal 2008; 8:229-236.
100. Brunner F, Schmid A, Kissling R, Held U, Bachmann LM. Bisphosphonates for the therapy of complex regional pain syndrome I-systematic review. Eur J Pain2009; 13:17-21.
101. Maillefert JF, Chatard C, Owen S, Peere T, Tavernier C, Tebib J. Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis 1995; 54:687.
102. Cortet B, Flipo RM, Coquerelle P, Duquesnoy B, Delcambre B. Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin Rheumatol 1997; 16:51-56.
103. Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology (Oxford) 2001; 40:1394-1397.
104. Breuer B, Pappagallo M, Ongseng F, Chen CI, Goldfarb R. An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain 2008; 24:685-689.
105. Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 2004; 5:276-280.
106. Varenna M, Adami S, Rossini M, Gatti D, Idolazzi L, Zucchi F, Malavolta N, Sinigaglia L. Treatment of complex regional pain syndrome type I with neridronate: A randomized, double-blind, placebocontrolled study. Rheumatology (Oxford) 2012; (ahead of print)
107. Varenna M, Zucchi F, Ghiringhelli D, Binelli L, Bevilacqua M, Bettica P, Sinigaglia L. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol 2000; 27:1477-1483.